Abstract LB_A10: Efficacy of ATR inhibitor berzosertib plus topotecan or topotecan alone in patients with relapsed small cell lung cancer: A randomized clinical trial
Nobuyuki Takahashi(Ministry of Agriculture, Forestry and Fisheries), Anish Thomas(National Cancer Institute), Alexander D. Fuld(Dartmouth–Hitchcock Medical Center), Linda Sciuto(National Cancer Institute), Christopher W. Schultz(National Cancer Institute), Christophe E. Redon(Center for Cancer Research), Chante Graham(National Cancer Institute), Melissa L. Abel(National Institutes of Health), Hirva Mamdani(Wayne State University), Ajit Kumar Sharma(National Cancer Institute), Manan Krishnamurthy(National Institutes of Health), Yves Pommier(National Cancer Institute), Seth M. Steinberg(National Institutes of Health), Mirit I. Aladjem(National Institutes of Health), Brett Schroeder(National Cancer Institute), Robbie Kattappuram(National Cancer Institute), Jimmy Ruiz(Wake Forest University), W. Jeffrey Petty(Atrium Health Wake Forest Baptist), Aman Chauhan(University of Kentucky), Justin Malin(National Institutes of Health), Meenakshi Shelat(National Cancer Institute), Samantha Nichols(National Cancer Institute), Danielle Pinkiert(National Cancer Institute), Deep Upadhyay(National Cancer Institute), Jorge J. Nieva(University of Southern California), Zhonglin Hao(Markey Cancer Center), Shubhank Goyal(National Cancer Institute), Elaine Shum(NYU Langone’s Laura and Isaac Perlmutter Cancer Center), Hirity Shimellis(National Cancer Institute), Liza C. Villaruz(University of Pittsburgh Medical Center), Jonathan W. Riess(Comprehensive Blood & Cancer Center), Jose M. Pachecho(University of Colorado Cancer Center), Jun Zhang(OSF HealthCare), Rajesh Kumar(National Cancer Institute), Steven D. Gore(Yale Cancer Center), Rasa Vilimas(National Cancer Institute), Jessie McGlone(National Cancer Institute), Parth Desai(The University of Texas MD Anderson Cancer Center)
Cited by 0
Related Papers
Non–Small Cell Lung Cancer, Version 3.2022, NCCN Clinical Practice Guidelines in Oncology
|Journal of the National Comprehensive Cancer Network|2022|1.4k
Azacitidine Prolongs Overall Survival Compared With Conventional Care Regimens in Elderly Patients With Low Bone Marrow Blast Count Acute Myeloid Leukemia
|Journal of Clinical Oncology|2009|963
Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
|Journal of Hepatology|2016|817
Non–Small Cell Lung Cancer, Version 4.2024
|Journal of the National Comprehensive Cancer Network|2024|746
Liquid Biopsy for Advanced Non-Small Cell Lung Cancer (NSCLC): A Statement Paper from the IASLC
|Journal of Thoracic Oncology|2018|661